Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
SeekPeptides members access detailed cost comparison tools, provider reviews, and protocol guides that help optimize every aspect of peptide treatment
doi: 10.4049/jimmunol.1601346 81 GanesanRRasoolM
The opportunities in these indications can be assessed by deploying effective new product planning / opportunity assessment methodologies, including evaluating the following for each potential indication: Level of in-class / competitive activity Likelihood of technical and regulatory success (i.e., based on scientific rationale and regulatory precedent) Level and nature of unmet needs for new therapies in the disease area of interest Potential for GLP1-s to address these unmet needs Commercial attractiveness of market Potential speed to market Alignment with individual manufacturer portfolio / strategy / capabilities Conclusion Incretin mimetics have had an immense and growing impact on patient outcomes
Will they be affordable and covered by insurance
*Altern Ther Health Med.* 27(S1):8-13
US$ 25.67
US$ 28.02
US$ 25.89
US$ 24.32
US$ 25.01
